Showing results (1-10 of 306) with videos related to
Sort By:
Pageof 31
Current Opinion in Pulmonary Medicine|July 23, 2013
Extracellular matrix microenvironment contributes actively to pulmonary fibrosisChiko Shimbori, Jack Gauldie, Martin KolbEuropean Respiratory Review : an Official Journal of the European Respiratory Society|December 3, 2013
Fibrocytes in pulmonary fibrosis: a brief synopsisShyam Maharaj, Chiko Shimbori, Martin KolbRespirology (Carlton, Vic.)|June 26, 2015
Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersNathan Hambly, Chiko Shimbori, Martin KolbAmerican Journal of Respiratory Cell and Molecular Biology|November 9, 2017
Lysyl Oxidase-Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1-induced Pulmonary FibrosisPierre-Simon Bellaye, Chiko Shimbori, Chandak Upagupta, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|June 29, 2018
Matrix abnormalities in pulmonary fibrosisChandak Upagupta, Chiko Shimbori, Rahmah Alsilmi, et al.The Journal of Pathology|July 19, 2016
Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosisChiko Shimbori, Pierre-Simon Bellaye, Jiaji Xia, et al.American Journal of Respiratory and Critical Care Medicine|January 16, 2016
Stretch-induced Activation of Transforming Growth Factor-β1 in Pulmonary FibrosisAaron R Froese, Chiko Shimbori, Pierre-Simon Bellaye, et al.The European Respiratory Journal|July 7, 2018
Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertensionPierre-Simon Bellaye, Toyoshi Yanagihara, Elise Granton, et al.Expert Review of Respiratory Medicine|October 22, 2013
New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational researchEva Baroke, Jack Gauldie, Martin KolbRespiratory Research|January 25, 2002
A new direction in the pathogenesis of idiopathic pulmonary fibrosis?Jack Gauldie, Martin Kolb, Patricia J SimePageof 31